ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
15.19
-0.77 (-4.82%)
Aug 20, 2026, 4:00 PM EDT - Market closed
ClearPoint Neuro Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 42.28 | 36.97 | 31.39 | 23.96 | 20.55 | 16.3 | |
Revenue Growth | 25.86% | 17.78% | 31.04% | 16.56% | 26.09% | 27.05% |
Cost of Revenue | 15.81 | 14.28 | 12.27 | 10.34 | 7.02 | 5.18 |
Gross Profit | 26.47 | 22.69 | 19.12 | 13.61 | 13.53 | 11.12 |
Selling, General & Admin | 39.87 | 31.16 | 26.46 | 24.35 | 18.97 | 15.22 |
Research & Development | 15.84 | 13.9 | 12.39 | 11.71 | 10.89 | 9.28 |
Operating Expenses | 55.71 | 45.06 | 38.86 | 36.06 | 29.86 | 24.5 |
Operating Income | -29.24 | -22.36 | -19.73 | -22.45 | -16.33 | -13.37 |
Interest Expense | -4.82 | -2.39 | -0.52 | - | -0.08 | -0.97 |
Interest & Investment Income | 1.42 | 1.21 | 1.39 | 0.39 | - | - |
Other Non Operating Income (Expenses) | -0.14 | -0.15 | -0.04 | -0.03 | -0.02 | -0.06 |
EBT Excluding Unusual Items | -32.78 | -23.69 | -18.9 | -22.09 | -16.44 | -14.41 |
Merger & Restructuring Charges | -1.8 | -1.8 | - | - | - | - |
Pretax Income | -34.58 | -25.49 | -18.9 | -22.09 | -16.44 | -14.41 |
Income Tax Expense | -0.02 | 0.06 | 0.01 | - | - | - |
Net Income | -34.57 | -25.54 | -18.91 | -22.09 | -16.44 | -14.41 |
Net Income to Common | -34.57 | -25.54 | -18.91 | -22.09 | -16.44 | -14.41 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 29 | 28 | 27 | 25 | 24 | 21 |
Shares Outstanding (Diluted) | 29 | 28 | 27 | 25 | 24 | 21 |
Shares Change | 5.24% | 4.76% | 9.84% | 1.75% | 16.63% | 30.82% |
EPS (Basic) | -1.18 | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 |
EPS (Diluted) | -1.18 | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31.29 | -24.45 | -9.23 | -14.44 | -16.42 | -12.87 |
Free Cash Flow Per Share | -1.07 | -0.86 | -0.34 | -0.59 | -0.68 | -0.62 |
Gross Margin | 62.61% | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% |
Operating Margin | -69.17% | -60.49% | -62.87% | -93.70% | -79.47% | -82.05% |
Profit Margin | -81.76% | -69.08% | -60.26% | -92.21% | -79.97% | -88.41% |
Free Cash Flow Margin | -74.01% | -66.13% | -29.39% | -60.27% | -79.90% | -78.93% |
EBITDA | -28.21 | -21.48 | -18.75 | -21.82 | -16.09 | -13.22 |
EBITDA Margin | -66.73% | -58.10% | -59.75% | -91.09% | -78.28% | -81.08% |
D&A For EBITDA | 1.03 | 0.88 | 0.98 | 0.63 | 0.24 | 0.16 |
EBIT | -29.24 | -22.36 | -19.73 | -22.45 | -16.33 | -13.37 |
EBIT Margin | -69.17% | -60.49% | -62.87% | -93.70% | -79.47% | -82.05% |
Revenue as Reported | 42.28 | 36.97 | 31.39 | 23.96 | 20.55 | 16.3 |